Literature DB >> 34467435

Health-related quality of life after esophagectomy in patients with esophageal cancer.

Yasushi Toh1, Masaru Morita2, Manabu Yamamoto2, Yuichiro Nakashima2, Masahiko Sugiyama2, Hideo Uehara2, Yoshiaki Fujimoto2, Yuki Shin2, Keiichi Shiokawa2, Emi Ohnishi3, Tomonari Shimagaki3, Yohei Mano3, Keishi Sugimachi3.   

Abstract

Esophageal cancer is one of the malignant tumors with the poorest prognosis. Esophagectomy, which is the mainstay of curative-intent treatments, imposes excessive surgical stress on the patients, and postoperative morbidity and mortality rates after esophagectomy remain high. On the other hand, the number of survivors after esophagectomy for esophageal cancer is increasing due to recent improvements in surgical techniques and multidisciplinary treatments for this cancer. However, esophagectomy still has a great influence on the fundamental aspect of patients' lives, that is, the health-related quality of life (HR-QOL), including their physical, emotional, and social functions in the short- and long-term postoperatively. HR-QOL is a multifactorial concept used to assess the symptoms and functional changes caused by the disease itself and treatments from the patients' perspectives. Therefore, assessing the HR-QOL of patients with esophageal cancer after esophagectomy is becoming increasingly important. However, the status of HR-QOL changes after esophagectomy has not been satisfactorily evaluated, and there is no worldwide consensus as to how the postoperative HR-QOL can be improved. This review aimed to raise awareness of healthcare providers, such as surgeons and nurses, on the importance of HR-QOL in patients with esophageal cancer after curative-intent esophagectomy by providing multifaceted information concerning the short- and long-term HR-QOLs, including the status of changes and the determinants of HR-QOL after esophagectomy, and furthermore, essential points for improvement of HR-QOL after esophagectomy.
© 2021. The Japan Esophageal Society.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; Health-related quality of life; Survivors

Mesh:

Year:  2021        PMID: 34467435     DOI: 10.1007/s10388-021-00874-6

Source DB:  PubMed          Journal:  Esophagus        ISSN: 1612-9059            Impact factor:   4.230


  54 in total

1.  Oesophageal cancer: risks, prevention, and diagnosis.

Authors:  Sri G Thrumurthy; M Asif Chaudry; Sasha S D Thrumurthy; Muntzer Mughal
Journal:  BMJ       Date:  2019-07-09

Review 2.  Minimally Invasive Esophagectomy.

Authors:  Pieter Christiaan van der Sluis; Dimitrios Schizas; Theodore Liakakos; Richard van Hillegersberg
Journal:  Dig Surg       Date:  2019-05-16       Impact factor: 2.588

3.  Health-related quality of life and treatment modality among esophageal squamous cell carcinoma survivors: A prospective study using time to deterioration model analysis.

Authors:  Shuang Liu; Zheng Lin; Jianbo Lin; Huilin Chen; Qianwen Xie; Wenqing Rao; Yuanmei Chen; Kaili Yu; Zhijian Hu
Journal:  J Surg Oncol       Date:  2020-10-30       Impact factor: 3.454

Review 4.  Systematic review of health-related quality of life after esophagectomy for esophageal cancer.

Authors:  Marco Scarpa; Stefano Valente; Rita Alfieri; Matteo Cagol; Giorgio Diamantis; Ermanno Ancona; Carlo Castoro
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

5.  Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Nils Homann; Claudia Pauligk; Thorsten O Goetze; Johannes Meiler; Stefan Kasper; Hans-Georg Kopp; Frank Mayer; Georg Martin Haag; Kim Luley; Udo Lindig; Wolff Schmiegel; Michael Pohl; Jan Stoehlmacher; Gunnar Folprecht; Stephan Probst; Nicole Prasnikar; Wolfgang Fischbach; Rolf Mahlberg; Jörg Trojan; Michael Koenigsmann; Uwe M Martens; Peter Thuss-Patience; Matthias Egger; Andreas Block; Volker Heinemann; Gerald Illerhaus; Markus Moehler; Michael Schenk; Frank Kullmann; Dirk M Behringer; Michael Heike; Daniel Pink; Christian Teschendorf; Carmen Löhr; Helga Bernhard; Gunter Schuch; Volker Rethwisch; Ludwig Fischer von Weikersthal; Jörg T Hartmann; Michael Kneba; Severin Daum; Karsten Schulmann; Jörg Weniger; Sebastian Belle; Timo Gaiser; Fuat S Oduncu; Martina Güntner; Wael Hozaeel; Alexander Reichart; Elke Jäger; Thomas Kraus; Stefan Mönig; Wolf O Bechstein; Martin Schuler; Harald Schmalenberg; Ralf D Hofheinz
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

6.  A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database.

Authors:  Hiroya Takeuchi; Hiroaki Miyata; Mitsukazu Gotoh; Yuko Kitagawa; Hideo Baba; Wataru Kimura; Naohiro Tomita; Tohru Nakagoe; Mitsuo Shimada; Kenichi Sugihara; Masaki Mori
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

7.  Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.

Authors:  Pieter C van der Sluis; Sylvia van der Horst; Anne M May; Carlo Schippers; Lodewijk A A Brosens; Hans C A Joore; Christiaan C Kroese; Nadia Haj Mohammad; Stella Mook; Frank P Vleggaar; Inne H M Borel Rinkes; Jelle P Ruurda; Richard van Hillegersberg
Journal:  Ann Surg       Date:  2019-04       Impact factor: 12.969

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Quality of life after esophageal resection.

Authors:  Wendy Jo Svetanoff; Rose McGahan; Saurabh Singhal; Carrie Bertellotti; Sumeet K Mittal
Journal:  Patient Relat Outcome Meas       Date:  2018-04-04

Review 10.  Patient reported outcomes (PROs) after minimally invasive and open esophagectomy.

Authors:  John J Brady; Tadeusz D Witek; James D Luketich; Inderpal S Sarkaria
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.